In light of a federal ruling on April 21, 2023, IDFPR has issued an UPDATED statement about Mifepristone in Illinois. See the statement by clicking here.
October 27, 2022 | IDFPR Position in Litigation about Transfers of Conditional Licenses
July 12, 2022 | IDFPR Statement on JCAR Extension
July 1, 2022 | FAQs About the Conditional Licensing Process
July 1, 2022 | Guidance | 1,500 Foot Prohibition Guidance
Agencies
Services